Dietary Biotin (Vitamin B7)

Overview

Biotin (vitamin B7, formerly vitamin H) is a water-soluble vitamin that serves as a covalently bound prosthetic group for five carboxylase enzymes in humans. These biotin-dependent carboxylases are essential for fatty acid synthesis, amino acid catabolism, and gluconeogenesis. Biotin is widely available in foods and is also synthesized by intestinal bacteria, making frank deficiency rare in healthy individuals. However, certain genetic conditions, medications, and dietary factors can precipitate deficiency.

Biological Functions

• Acetyl-CoA carboxylase (ACC): Rate-limiting step in fatty acid synthesis; converts acetyl-CoA to malonyl-CoA
• Pyruvate carboxylase (PC): Key enzyme in gluconeogenesis; converts pyruvate to oxaloacetate
• Propionyl-CoA carboxylase (PCC): Catabolism of odd-chain fatty acids and certain amino acids (isoleucine, valine, methionine, threonine)
• 3-Methylcrotonyl-CoA carboxylase (MCC): Leucine catabolism
• Gene expression: Histones can be biotinylated, potentially affecting gene regulation
• Cell signaling: Emerging evidence for non-carboxylase functions

Health Significance

Biotin has gained significant consumer attention for its purported benefits for hair, skin, and nail health. While biotin deficiency clearly causes hair loss and dermatitis, evidence that supplementation improves these conditions in biotin-replete individuals is limited. Clinically, biotin is most relevant in the context of inherited metabolic disorders affecting carboxylase function, certain medications, and a critical laboratory interference issue where high-dose biotin supplementation can cause erroneous results in immunoassays.

Clinical Interpretation Guidelines

• Adequate Intake (AI): Only AI values exist (no RDA) due to insufficient data
• Daily monitoring: Compare cumulative intake against AI values
• Trend analysis: Assess 7-14 day averages
• Supplement awareness: High-dose biotin supplements (common for hair/nail claims) rarely captured in food logs
• Laboratory interference: CRITICAL - biotin can interfere with immunoassays (troponin, thyroid tests, hormone panels)
• Urinary 3-hydroxyisovaleric acid: Elevated levels suggest marginal biotin deficiency

Deficiency

Primary deficiency is rare but recognized causes include:

Genetic disorders:

• Biotinidase deficiency: Inability to recycle biotin from biocytin; screened at birth
• Holocarboxylase synthetase deficiency: Impaired attachment of biotin to carboxylases

Acquired deficiency symptoms:

• Dermatologic: Periorificial (around eyes, nose, mouth) scaly, erythematous dermatitis; seborrheic-like rash
• Hair: Alopecia (hair loss), loss of hair color
• Neurological: Lethargy, hypotonia, developmental delay (infants); depression, paresthesias, hallucinations (adults)
• Metabolic: Lactic acidosis, organic aciduria
• Immune: Increased susceptibility to infections (Candida)

At-risk populations:

• Raw egg white consumption (avidin binds biotin and prevents absorption)
• Parenteral nutrition without biotin supplementation
• Chronic anticonvulsant therapy (especially valproic acid, carbamazepine, phenytoin)
• Chronic alcohol use
• Pregnancy (marginal biotin deficiency is common)
• Inflammatory bowel disease
• Biotinidase deficiency carriers (heterozygotes may have reduced activity)

Toxicity/Excess

No Tolerable Upper Intake Level (UL) has been established for biotin. Even at very high supplemental doses (up to 200 mg/day in some studies), no adverse effects have been consistently reported.

CRITICAL LABORATORY INTERFERENCE: High-dose biotin supplementation (commonly 5,000-10,000 mcg/day for hair/nails) can cause significant interference with immunoassays that use biotin-streptavidin technology:

• Troponin: False decreases can mask myocardial infarction
• Thyroid function tests (TSH, T4, T3): Results may appear hyperthyroid (low TSH, elevated T3/T4) or hypothyroid depending on assay design
• Parathyroid hormone: Falsely elevated or decreased
• Reproductive hormones (FSH, LH, estradiol, testosterone): Variable interference
• Tumor markers (PSA, CA-125): False results possible
• BNP/NT-proBNP: May affect heart failure assessment

FDA has issued warnings. Patients should be advised to discontinue biotin supplements 2-7 days before laboratory testing depending on dose.

Food Sources

• Excellent sources (>10 mcg/serving): Beef liver, egg yolk (cooked), salmon, pork
• Good sources (5-10 mcg/serving): Sunflower seeds, sweet potato, almonds, spinach, broccoli
• Moderate sources (<5 mcg/serving): Cheese, milk, whole wheat bread, banana, mushrooms, cauliflower

Note: Egg whites contain avidin, which tightly binds biotin and prevents absorption. Cooking denatures avidin and eliminates this effect. Chronic consumption of raw egg whites can cause deficiency.

Special Populations

• Pregnancy: Marginal biotin deficiency is common (up to 50% of pregnant women); may affect fetal development; teratogenic in animal studies at deficient states
• Infants on formula: Ensure formula contains adequate biotin
• Biotinidase deficiency patients: Require lifelong biotin supplementation (5-20 mg/day)
• Patients on anticonvulsants: Valproic acid, carbamazepine, phenytoin, and phenobarbital may deplete biotin; monitor and consider supplementation
• Long-term parenteral nutrition: Requires biotin in TPN formulation
• Chronic alcohol users: May have impaired biotin status
• Smokers: Some evidence of lower biotin status
• Patients taking high-dose biotin supplements: Counsel regarding laboratory interference

Drug Interactions

• Anticonvulsants (valproic acid, carbamazepine, phenytoin, phenobarbital, primidone): Accelerate biotin catabolism and may cause deficiency with long-term use
• Antibiotics (long-term): May reduce intestinal bacterial biotin synthesis
• Isotretinoin: May affect biotin metabolism
• Alpha-lipoic acid: Competes for cellular uptake via same transporter
• Pantothenic acid (high doses): May compete for intestinal absorption
• Raw egg whites: Avidin protein binds biotin irreversibly

Note on laboratory tests: While not a drug interaction per se, biotin supplementation interferes with streptavidin-biotin immunoassays, affecting numerous clinical tests.

Caveats & Limitations

• Adequate Intake only: No RDA established; AI based on limited data
• Self-reported intake: Accuracy depends on user diligence and food database quality
• Supplement use underreported: High-dose biotin supplements common but often not logged
• Bacterial contribution: Intestinal synthesis not reflected in dietary intake data
• Bioavailability: Varies by food source; protein-bound biotin requires biotinidase
• No direct measurement: HealthKit data reflects intake estimates, not serum levels
• Laboratory interference critical: Healthcare providers must ask about biotin supplements
• Limited evidence for cosmetic benefits: Hair/skin/nail claims largely unsubstantiated in biotin-replete individuals